The SEER as a Prophet: Epidemiological Analysis as a Harbinger of Evolving Priorities in Gastroenteropancreatic Neuroendocrine Neoplasia Abstract #318

Introduction: Previous epidemiology analysis of tumor registries established that gastroenteropancreatic neuroendocrine neoplasms (GEP-NETs) were both more prevalent, and more malignant, than previously recognized.
Aim(s): To define how the epidemiology (incidence, ethnicity, gender, survival) of GEP-NETs has evolved in the US to determine priorities for current research.
Materials and methods: We interrogated the most recent release (1973 to 2007) of the Surveillance, Epidemiology and End Results (SEER) database using the SEERStat analysis tool, examining organ- and cell-specific neuroendocrine tumors localized to the gastrointestinal tract and pancreas. Specific foci were gender/ethnicity; outcomes were incidence and survival.
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: Dr. Mark Kidd

To read results and conclusion, please login ...

Further abstracts you may be interested in

#306 The Risk of Metachronous Cancers In Patients with Small Intestinal Carcinoid Tumors
Introduction: Small intestinal carcinoids (SIC) are the most common small bowel malignancies. No population-based study has examined the risk for, and prognosis of, metachronous cancers and SICs.
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: Michelle Kim
#390 An Increasing Incidence of GEP-NETs in Chengdu City with a Population of 14 Million in China
Introduction: The annual incidence of GEP-NETs in China is still unclear. All histopathology and cytopathology reports have yet to be collected in a national archive. No national or regional survey on GEP-NETs has been approved. West China Hospital (WCH), a university hospital located in Chengdu City with a population of 14 million, has established a series of databases in recent years.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Professor Tang Chengwei
Authors: Guo L, Wang C, Liu W, Zhong M, ...
#427 Gastric Carcinoids: Prevalence in Europe and USA, and Rationale for Treatment with YF476, a Gastrin Receptor Antagonist
Introduction: Gastric carcinoids (GC) are tumors arising from enterochromaffin-like (ECL) cells in the gastric mucosa. Most are caused by hypergastrinaemia, which stimulates ECL-cell growth. YF476 is a potent, selective and orally active gastrin receptor antagonist in humans in vitro and in vivo. YF476 prevented and caused shrinkage of GC in animal models of the condition.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Dr Malcolm Boyce
Authors: Boyce M, ...
#500 Duodenal Carcinoid Tumors are Associated with Increased Survival and Earlier Detection When Compared with Jejunal or Ileal Carcinoids: A Population Based Study
Introduction: Seventy to eighty percent of small intestinal carcinoids (SIC) are found incidentally. Jejunal and ileal lesions can often be resected locally, but advanced duodenal carcinoids require high-risk pancreaticoduodenectomy.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Dr. Sunil Amin
Authors: Amin S, Kim M, Frucht H, ...
#535 Epidemology of Neuroendocrine Tumors in Ontario: A 15-year Population-Based Study
Introduction: A recent study of the SEER database in the United States showed a 5-fold increase in neuroendocrine tumors (NETs) over the last 30 years. Conflicting reports of incidence trends have been reported worldwide.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Dr. Simron Singh
Authors: Singh S, Cukier M, Saskin R, Liu N, ...